|
 |
RCGAction
The Monthly Newsletter
and Planning Calendar of the St. Louis RCGA
|
Wyeth BioPharma
$230 Million Expansion Strengthens Region’s BioBelt Status
Above:
From left to right: Reggie Lambert (Wyeth employee), Ed Jones
(National Hemophilia Foundation), Mike Kamarck (Wyeth), Bernard
Poussot (Wyeth), Jim Miller (Wyeth), Gov. Holden, Bob Essner (Wyeth),
Babatunde Dienbo (Mayor of Berkeley), and Judy Salyer (Wyeth employee)
Wyeth BioPharma, one of the nation’s leading life sciences companies,
held a groundbreaking ceremony in April at its 300-employee campus
in Berkeley, with Governor Bob Holden marking the second phase of
the company’s planned growth initiative. Wyeth, which manufactures
biopharmaceuticals, hired more than 140 new employees in St. Louis
last year, with plans to hire 150 more engineers, biomanufacturing
technicians, project managers, and scientists by the end of this
year, significantly strengthening the St. Louis region as the BioBelt:
The Center of Plant and Life Sciences. When completed in 24 months,
Wyeth’s new $230 million 250,000-square-foot biopharmaceutical production
facility will employ nearly 600 people.
According to Virginia Baldwin Gilbert, reporter for the St. Louis
Post-Dispatch, Wyeth’s investment in this facility gives another
strong third-party endorsement when the region’s economic developers
are pitching national site consultants looking for locations for
some of the big pharmaceutical companies.
The RCGA, through Director of Business Development Lynda Andrews,
has been working with Wyeth BioPharma Plant Manager Jim Miller and
his colleagues for nearly two years on this major expansion project—in
partnership with St. Louis County, the State of Missouri, and St.
Louis Community College.
This expanded
production facility and its employees represent an important asset
in the BioBelt, and in building a critical mass of life sciences
companies and talent in the St. Louis region. Like Sigma-Aldrich,
which opened its new Life Science and High Technology Center earlier
this year, Wyeth’s groundbreaking is another shining example of
how strong an asset base the St. Louis region has in its plant and
life science industry cluster. |
|
|
|
|
-
- - - - - - - - - - - - - - - - -
-
- - - - - - - - - - - - - - - - -
-
- - - - - - - - - - - - - - - - -
-
- - - - - - - - - - - - - - - - -
|